Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on The Utility of Tafasitamab

From Hematologic Oncology Update · 15:59

Show by Dr. Neil Love

Featuring an interview with Dr Matthew Lunning, including the following topics:Tafasitamab for follicular lymphoma (0:00)frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)CME information and select publications

More episodes of Hematologic Oncology Update

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.